HIGHLIGHTS
- who: Palaniyandi Ravanan from the India, Université de La Réunion, Institut National de la Santé et de la Recherche Médicale, UMR Diabète have published the paper: CDDO and ATRA Instigate Differentiation of IMR32 Human Neuroblastoma Cells, in the Journal: (JOURNAL)
- what: The authors report that simultaneous treatment with CDDO and ATRA induces neurite outgrowth, increases the percentage of cells bearing more than two neurites, reduces cell viability, upregulates differentiation markers, and down-regulates MYCN mRNA level in IMR32 cells.
- how: The authors used IMR32 cell line which is a wellestablished . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.